People are three times more likely to undergo at-home colon cancer screening if they're provided a free test, a new study ...

Despite being an indirect comparison, the study suggests FITs as a cost-effective alternative for improving noninvasive CRC ...

Colorectal cancer screening is an effective tool for catching the disease early when it's most treatable, yet it is ...

For colorectal cancer screening, colonoscopy and stool tests are more effective and less costly than novel first-generation ...

Adults aged 45-49 years are as likely as those aged 50 years to complete a fecal immunochemical test (FIT) as an initial screen for colorectal cancer (CRC) and follow-up with a colonoscopy if ...

Quantitative fit testing is the preferred testing method. The ambient aerosol condensation nuclei counting (CNC) method, using a Portacount® Plus instrument, has been selected as the quantitative fit ...

cf-bDNA testing can reduce CRC incidence and mortality but is less effective and more costly than colonoscopy and FIT. The test may increase screening participation among those who avoid ...

and a FIT-DNA test (Cologuard), which looks for blood and altered DNA and gets repeated every three years. The Shield blood test, manufactured by Guardant Health, is the latest screening tool to ...

fecal immunochemical test (FIT), or colonoscopy has been shown to improve screening rates. "Someone who doesn't want a colonoscopy quite often will do a stool test," said Smith. The new cfDNA ...

This information is about using the FIT test for people who have symptoms that could be caused by bowel cancer. We have separate information about using FIT for the Bowel Cancer Screening Programme ...